Mar 10, 2026 04:10PM vTv Therapeutics (VTVT) Tops Q3 EPS by 42c

Jan 23, 2026 05:25AM Roth/MKM Starts vTv Therapeutics (VTVT) at Buy

Jan 5, 2026 05:30AM TD Cowen Starts vTv Therapeutics (VTVT) at Buy

Dec 22, 2025 07:10AM vTv Therapeutics (VTVT) PT Raised to $47 at H.C. Wainwright

Nov 6, 2025 06:30PM vTv Therapeutics (VTVT) Misses Q3 EPS by 108c

Oct 3, 2025 04:40PM vTv Therapeutics (VTVT) files for 15.9M share offering by selling stockholders

Aug 12, 2025 06:01PM vTv Therapeutics (VTVT) Misses Q2 EPS by 92c

May 19, 2025 09:00AM vTv Therapeutics (VTVT) Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

May 15, 2025 06:31PM vTv Therapeutics (VTVT) Misses Q1 EPS by 77c

May 15, 2025 12:00PM vTv Therapeutics (VTVT) Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes

Apr 9, 2025 06:03AM H.C. Wainwright Starts vTv Therapeutics (VTVT) at Buy

Mar 17, 2025 08:30AM vTv Therapeutics (VTVT) Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes

Mar 17, 2025 08:27AM vTv Therapeutics (VTVT) Halted, News Pending

Nov 13, 2024 06:31AM vTv Therapeutics (VTVT) Misses Q3 EPS by 88c

Aug 8, 2024 07:33PM vTv Therapeutics (VTVT) Misses Q2 EPS by 81c

Jul 26, 2024 04:05PM vTv Therapeutics (VTVT) Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold

Jul 26, 2024 04:02PM vTv Therapeutics (VTVT) Halted, News Pending

Jun 24, 2024 04:08PM vTv Therapeutics (VTVT) Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes